TREATMENT ISSUES
Chairpersons: J.L. Rodicio (Madrid, Spain) - P.A. van Zwieten (Amsterdam, The Netherlands)
|
|
 |
|
Dementia
A. Coca (Barcelona, Spain)
[ WEBCAST ]
|
|
|

|
|
Atrial fibrillation and hypertension
A.J. Manolis (Athens, Greece)
[ WEBCAST ] |
|
|

|
|
Use of the 4th drug in the treatment of hypertension. The place of aldosterone antagonists and alpha-blockers
J. Redon (Valencia, Spain)
[ WEBCAST ] |
|
|

|
|
The patient with pre-hypertension
S. Julius ( Ann Arbor, MI, USA)
[ WEBCAST ] |
|
<< back
|